arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Cogent Biosciences, Inc.

COGT Health Care Biotechnology: Pharmaceutical Preparations
$31.02
▼ -5.4% Today
as of Jun 7, 07:11 ET
Last 30 days -14.64% Apr 28 → Jun 05
$30.54 $32.27 $34.00 $35.73 $37.46 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$32.37
High
$32.83
Low
$30.98
Volume
$2M
Avg Vol
$3M
Mkt Cap
$6.0B
P/E (TTM)
Beta
52w High
$43.73
52w Low
$5.49
Div Yield
Shares Out
$171M

Overview

52-week range
$5.49
$44
67% of range
Avg surprise (last 2)
+3.6%
Avg reaction (last 2)
-7.5%
50% positive
Latest IV / EM
77%
EM ±10.7% · $31 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.64$-0.59$-0.54$-0.48$-0.43 Actual $-0.59Actual $-0.64Actual $-0.49Actual $-0.43Actual $-0.52Actual $-0.52Est $-0.56Actual $-0.53Actual $-0.50Actual $-0.53Est $-0.53 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-97M$-88M$-80M$-71M$-62M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 5, 2026Mar/2026 $-0.53 $-0.53 0.0% -1.9% +0.7% earnings
Tue Sep 30, 2025Sep 2025 $-0.50 financials
Mon Jun 30, 2025Jun 2025 $-0.53 financials
Tue May 6, 2025Mar/2025 $-0.52 $-0.56 +7.1% -15.6% earnings
Mon Sep 30, 2024Sep 2024 $-0.52 financials
Sun Jun 30, 2024Jun 2024 $-0.43 financials
Sun Mar 31, 2024Mar 2024 $-0.49 financials
Sat Sep 30, 2023Sep 2023 $-0.64 financials
Fri Jun 30, 2023Jun 2023 $-0.59 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-104M$-83M$-76M$-75M$-75M$-64M
Net income$-97M$-81M$-74M$-72M$-71M$-59M
EPS (diluted)$-0.53$-0.50$-0.53$-0.52$-0.52$-0.43

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$241M$312M$125M$128M$126M$98M$97M$88M
Inventory
Total current assets$878M$910M$397M$245M$253M$296M$342M$370M
Total assets$903M$938M$426M$275M$284M$328M$384M$430M
Long-term debt$44M$44M$0
Total liabilities$295M$301M$123M$120M$65M$72M$69M$57M
Total equity$608M$636M$302M$155M$219M$256M$315M$373M

Implied volatility — last 90 days

72%74%77%79%82% Jun 07 — IV 77% · EM ±10.7%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.